Updated Jul 16, 2026
Piscitelli Dominic is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $1.14M.
Dominic Piscitelli is the Chief Financial Officer of Oric Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for cancer. He has been involved in the company's financial management and strategic planning.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-26 | ORIC | Oric Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 52.0K | $13.51 | $703K |
| 2026-02-26 | ORIC | Oric Pharmaceuticals, Inc. | M — Option exercise [10b5-1] | 52.0K | $4.36 | $227K |
| 2025-10-06 | ORIC | Oric Pharmaceuticals, Inc. | S — Open-market sale | 11.0K | $14.52 | $160K |
| 2025-10-06 | ORIC | Oric Pharmaceuticals, Inc. | M — Option exercise | 11.0K | $4.36 | $48K |
| 2025-07-01 | ORIC | Oric Pharmaceuticals, Inc. | S — Open-market sale | 20.0K | $10.05 | $201K |
| 2024-12-17 | ORIC | Oric Pharmaceuticals, Inc. | S — Open-market sale | 8.9K | $8.28 | $73K |
| 2024-12-17 | ORIC | Oric Pharmaceuticals, Inc. | M — Option exercise | 24.0K | $0.00 |
Dominic Piscitelli is the Chief Financial Officer of Oric Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for cancer. He has been involved in the company's financial management and strategic planning.…
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($1.14M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Piscitelli Dominic profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.